Concepedia

<i>PIK3CA</i>and<i>TP53</i>mutations predict overall survival of stage II/III colorectal cancer patients

Ajian Li, Huaguang Li, Erjiang Tang, Wei Wu, Ying Chen, Huihong Jiang, Moubin Lin, Lu Yin

World Journal of Gastroenterology · 2018 · 23 citations · 39 references

DOIFull text

Open access

Abstract

Double mutation of <i>PIK3CA</i> and <i>TP53</i> is correlated with a shorter OS in stage II/III CRC patients treated with 5-fluorouracil-based therapy.

References

39

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer · 2010 · 21.3K citations

, , +16

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Aimery de Gramont, Arié Figer, Michel Seymour et al. · Journal of Clinical Oncology · 2000 · 3.8K citations

High Frequency of Mutations of the <i>PIK3CA</i> Gene in Human Cancers

Yardena Samuels, Zhenghe Wang, Alberto Bardelli et al. · Science · 2004 · 3.4K citations

, , +15

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

J-Y Douillard, David Cunningham, AD Roth et al. · The Lancet · 2000 · 3.3K citations

, , +6

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

Charles G. Moertel, Thomas R. Fleming, John S. Macdonald et al. · New England Journal of Medicine · 1990 · 2.2K citations · Full text